1 2 3 4
News & Information
Biomarker Testing Needed Before African American Patients Choose Active Surveillance

Thomas Farrington, PHEN President, outlines why genomic biomarker testing is needed by African American patients before they choose active surveillance....
May 8th Webcast: Biomarker Testing Needed Before Making Treatment Decisions May 8th Webcast: Biomarker Testing Needed Before Making Treatment Decisions

Guest Speaker: Dr. Todd D. Cohen, Medical Director at Myriad Genetics

Evidence Supports Stereotactic Body Radiotherapy as a Standard of Care for Localized PC

Evidence supports stereotactic body radiotherapy — a highly precise radiation therapy delivered in shorter periods of time — as a standard treatment for people with localized prostate cancer.

Innovative Format is Key to Reaching & Educating African Americans About Prostate Cancer

The “Daddy’s Boys” stage play, presented on tour by PHEN, draws 1,000+ national attendees per performance.

Prostate cancer diagnoses, deaths decreasing worldwide

Prostate caner, one of the deadliest forms of cancer for men in the United States and worldwide, is on the decline.

African American Men Respond Better to Treatments For Advanced Prostate Cancer in Clinical Trials

New research shows that African American men who receive treatments for late-stage prostate cancer can live at least as long, or even longer than their Caucasian counterparts.


Partners